Abstract
IntroductionDermatological extraintestinal manifestations (EIM) in Inflammatory Bowel Disease (IBD) are well-recognised. Recently, IBD therapy-related skin disorders have garnered attention. We aimed to assess skin disorder prevalence, aetiology, and the impact...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
